Managing Serious Adverse Events from Ivermectin Treatment in Co-endemic Areas
Author Information
Author(s): Haselow Nancy J, Akame Julie, Evini Cyrille, Akongo Serge
Primary Institution: Helen Keller International
Hypothesis
How can community-directed treatment with ivermectin be adapted to minimize serious adverse events in areas co-endemic for onchocerciasis and loiasis?
Conclusion
A reinforced communication strategy is essential to motivate community participation in ivermectin treatment despite the risks of serious adverse events.
Supporting Evidence
- Serious adverse events have been reported in areas co-endemic for loiasis and onchocerciasis.
- Community participation is critical for the success of ivermectin treatment programs.
- Effective communication strategies can help reduce fears associated with ivermectin side effects.
Takeaway
When people in certain areas take a medicine called ivermectin, they can sometimes feel really sick. To help them feel better about taking it, we need to talk to them more and explain how to stay safe.
Methodology
The review discusses the need for better communication and management strategies based on community-level research and experiences from previous ivermectin treatment programs.
Potential Biases
Potential biases may arise from the community's fear and misconceptions about ivermectin side effects.
Limitations
The study highlights the lack of adequate health education and community participation in managing serious adverse events.
Participant Demographics
The study focuses on communities in Cameroon co-endemic for onchocerciasis and loiasis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website